dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

1st Workshop on Pharma Negotiations in the EU

Sotsiaalministeerium · 26. september 2018
Viit
1.4-4/3017-1
Registreeritud
26. september 2018
Dokumendi liik
Sissetulev kiri
Adressaat
European Commission
Saabumis/saatmisviis
e-post
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-4 Kutsed ja kirjavahetus rahvusvahelistel seminaridel, konverentsidel jt üritustel osalemiseks
Toimik
1.4-4/2018
Vastutaja
Eda Lopato (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Terviseala asekantsleri vastutusvaldkond, Ravimiosakond)
Lahendamise tähtaeg
12. oktoober 2018

Failid

  • 📎Draft agenda_1st Workshop on Pharmaceutical Negotiations in the EU - Bru....pdf218 KB
  • 📎E-kiri.pdf367 KB
  • 📎Visitors template.pdf274 KB

Sisu (failidest)

EU Health Programme/ OECD project on Access to Medicines 1st workshop on Building Capacity for Pharmaceutical Negotiations in the EU Borschette Conference Centre – rue Froissart 36 – 1049 Brussels Room 2A 19 October 2018, 09:00-17:30 DRAFT AGENDA Time Topic Speaker(s) or facilitator(s) 9.00 Welcome & Introductions 15 min Overview of workshop Matthew Brougham - What is the context and why it matters - Context and negotiation leverage, exercises to understand context and leverage - Case studies of good and poor outcomes – What can we learn, what would we do differently - Negotiating without leverage – Why an understanding of behavioural economics matters - Exercises to help understand BE in practice - Policy options to investigate The negotiating environment Francis Megerlin, - Class room presentation University of Strasbourg o The EU and national environment o What is the leverage – timing, access restrictions, substitutability, direct competition - Participant Q&A and discussion Break Insights on the industry’s approach to negotiations Sean Robbins, - What are the industry’s interests? Lattice Point Consulting and - What strategies does it employ to optimise their negotiation Former Head of International results? Pricing at Amgen - Participant Q&A and discussion 12.30 Lunch 14.00 Exercise – A fictitious pricing & reimbursement proposal within a context to get the group to determine a negotiating strategy - Participant discussion Group feedback and discussion – be prepared to discuss negotiation successes and failures and share insights given learnings Break Payer or government Insights Senior Government / Payer What success looks like and what created it? Representative (TBC) - Participant Q&A and discussion (Delegations are free to prepare in advance a short presentation on their experiences) 17.30 Wrap- up and next steps Follow- up workshop on Building Capacity for Pharmaceutical Negotiations in the EU* Topic – UNDERSTANDING THE PSYCHOLOGY OF NEGOTIATION [November 2018 Location to be confirmed] Time Topic Speaker(s) or facilitator(s) 9.00 Introduction to day 2 and summary of day 1 Matthew Brougham A behavioural economics perspective Adam Oliver, - Class room presentation London School of Economics - Q&A & Political Science ‘Real world’ examples of the impact of these insights on negotiations] Matthew Brougham Break Case study 1 - Insights from a negotiation with worse than anticipated outcomes - Discussion 12.30 Lunch Case study 2 - Insights from a negotiation with better than expected outcomes - Discussion Break Policy changes that might improve negotiation leverage of Buyers Matthew Brougham Francis Megerlin, University of Strasbourg Adam Oliver, London School of Economics & Political Science * This draft agenda is preliminary subject to change, taking in to account any specific topic raised during the first workshop in Brussels. NAME FIRSTNAME DATE OF BIRTH (dd/mm/yyyy) NATIONALITY (choose from the country code sheet) ID CARD Number Date of expiry of the ID Afghanistan AFG Y Albania ALB N Algeria DZA American Samoa ASM Andorra AND Angola AGO Anguilla AIA Antarctica ATA Antigua and Barbuda ATG Argentina ARG Armenia ARM Aruba ABW Australia AUS Austria AUT Azerbaijan AZE Bahamas BHS Bahrain BHR Bangladesh BGD Barbados BRB Belarus BLR Belgium BEL Belize BLZ Benin BEN Bermuda BMU Bhutan BTN Bolivia BOL Bosnia and Herzegovina BIH Botswana BWA Bouvet Island BVT Brazil BRA British Indian Ocean Territory IOT Brunei Darussalam BRN Bulgaria BGR Burkina Faso BFA Burundi BDI Cambodia KHM Cameroon CMR Canada CAN Cape Verde CPV Cayman Islands CYM Central African Republic CAF Chad TCD Chile CHL China CHN Christmas Island CXR Cocos (Keeling) Islands CCK Colombia COL Comoros COM Congo COG Congo, Democratic Republic of the COD Cook Islands COK Costa Rica CRI Côte d'Ivoire CIV Croatia HRV Cuba CUB Cyprus CYP Czech Republic CZE Denmark DNK Djibouti DJI Dominica DMA Dominican Republic DOM East Timor TMP Ecuador ECU Egypt EGY El Salvador SLV Equatorial Guinea GNQ Eritrea ERI Estonia EST Ethiopia ETH Faeroe Islands FRO Falkland Islands (Malvinas) FLK Fiji FJI Finland FIN France FRA French Guiana GUF French Polynesia PYF Gabon GAB Gambia GMB Georgia GEO Germany D Ghana GHA Gibraltar GIB Greece GRC Greenland GRL Grenada GRD Guadeloupe GLP Guam GUM Guatemala GTM Guinea GIN Guinea-Bissau GNB Guyana GUY Haiti HTI Heard and McDonald Islands HMD Holy See (Vatican City State) VAT Honduras HND Hong Kong HKG Hungary HUN Iceland ISL India IND Indonesia IDN Iran, Islamic Republic of IRN Iraq IRQ Ireland IRL Israel ISR Italy ITA Jamaica JAM Japan JPN Jordan JOR Kazakhstan KAZ Kenya KEN Kiribati KIR Korea, Democratic People's Republic of PRK Korea, Republic of KOR Kosovo XK Kuwait KWT Kyrgyzstan KGZ Lao People's Democratic Republic LAO Latvia LVA Lebanon LBN Lesotho LSO Liberia LBR Libyan Arab Jamahiriya LBY Liechtenstein LIE Lithuania LTU Luxembourg LUX Macedonia, The former Yugoslav Republic of MKD Madagascar MDG Malawi MWI Malaysia MYS Maldives MDV Mali MLI Malta MLT Marshall Islands MHL Martinique MTQ Mauritania MRT Mauritius MUS Mayotte MYT Mexico MEX Micronesia, Federated States of FSM Moldova, Republic of MDA Monaco MCO Mongolia MNG Montenegro MNE Montserrat MSR Morocco MAR Mozambique MOZ Myanmar MMR Namibia NAM Nauru NRU Nepal NPL Netherlands Antilles ANT Netherlands, Kingdom of the NLD New Caledonia NCL New Zealand NZL Nicaragua NIC Niger NER Nigeria NGA Niue NIU Norfolk Island NFK Northern Mariana Islands MNP Norway NOR Oman OMN Pakistan PAK Palau PLW Panama PAN Papua New Guinea PNG Paraguay PRY Peru PER Philippines PHL Pitcairn PCN Poland POL Portugal PRT Puerto Rico PRI Qatar QAT Réunion REU Romania ROU Russian Federation RUS Rwanda RWA Saint Helena SHN Saint Kitts and Nevis KNA Saint Lucia LCA Saint Pierre and Miquelon SPM Saint Vincent and the Grenadines VCT Samoa WSM San Marino SMR Sao Tome and Principe STP Saudi Arabia SAU Senegal SEN Serbia SCG Seychelles SYC Sierra Leone SLE Singapore SGP Slovakia SVK Slovenia SVN Solomon Islands SLB Somalia SOM South Africa ZAF South Georgia and the South Sandwich Isl. SGS Spain ESP Sri Lanka LKA Stateless XXA Sudan SDN Suriname SUR Svalbard and Jan Mayen Islands SJM Swaziland SWZ Sweden SWE Switzerland CHE Syrian Arab Republic SYR Taiwan Province of China TWN Tajikistan TJK Tanzania, United Republic of TZA Thailand THA Togo TGO Tokelau TKL Tonga TON Trinidad and Tobago TTO Tunisia TUN Turkey TUR Turkmenistan TKM Turks and Caicos Islands TCA Tuvalu TUV Uganda UGA UK of GB and North. Irel. Citizen GBR Ukraine UKR United Arab Emirates ARE United Nations Organization UNO United States of America USA United States of America Minor Outlying Isl. UMI Unspecified / Unknown XXX Uruguay URY Uzbekistan UZB Vanuatu VUT Venezuela VEN Viet Nam VNM Virgin Islands (Great Britian) VGB Virgin Islands (United States) VIR Wallis and Futuna Islands WLF Western Sahara ESH Yemen YEM Zambia ZMB Zimbabwe ZWE Dear Madams/ Sirs, Registration is now open for the first Workshop on Building Capacity for Pharmaceutical Negotiations in the EU. This workshop, with the funding from the EU Health Programme and the support of the OECD, is intended for officials of all EU Member States’ governments, government agencies or health care payers who are directly involved in negotiating pharmaceutical prices and contracts with pharmaceutical companies. It will be the first of the series under this project: • BRUSSELS - this is the first part that takes place on 19 October 2018 on European Commission premises. • EU CAPITAL – the second part will take place in late November 2018 in an EU capital (the exact location and date will be communicated shortly). Attached the preliminary agenda, a revised one will be communicated to the registered users – together with the background/ room documents. Matthew Brougham, President of Brougham Consulting and former CEO of Pharmac in New Zealand, will facilitate both days. The workshop will take a hands-on approach, relying on case studies and extensive discussions, to provide participants with tools to understand and increase their leverage in negotiations with the industry. External contributions by academic experts will help analyse the negotiation environment and provide tools for negotiations based on psychology and behavioural economics. Delegations are also encouraged to share their own experiences at the date of the workshop and contribute to the informal discussions. Participants are expected to cover costs of their own, travel and accommodation. We invite you to register participants by sending filled the attached excel file by email to: SANTE-ACCESS- [email protected]. Registration will be open until 12 October 2018. This invitation is shared to the EU members of the OECD Health Committee. Kind regards, European Commission SANTE-B1: Performance of National Health Systems
Allikas: Sotsiaalministeerium dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel